Considering that Russell and colleagues have demonstrated the ability of ZAG to reduce reactive oxygen species (ROS) production and to counter muscle atrophy associated with insulin resistance and other catabolic conditions [58], the decrease of ZAG that we found in WS seems to support the hypothetical role of oxidative stress in CFS. The gene discussed is AZGP1; the disease is Insulin resistance.